Stockscreener 앱 받기
1.7307
3.31%
-0.0593
전일 마감가:
$1.79
열려 있는:
$1.79
하루 거래량:
57,652
Relative Volume:
0.17
시가총액:
$53.99M
수익:
$1.05M
순이익/손실:
$-48.82M
주가수익비율:
-0.9457
EPS:
-1.83
순현금흐름:
$-47.49M
1주 성능:
+2.41%
1개월 성능:
+21.88%
6개월 성능:
+34.16%
1년 성능:
-77.87%
1일 변동 폭
$1.72
$1.79
1주일 범위
$1.6301
$1.89
52주 변동 폭
$1.06
$7.9499
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
명칭
Actinium Pharmaceuticals Inc
전화
646-767-3870
주소
275 Madison Avenue, 7th Floor, New York, NY
ATNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.7307 | 55.84M | 1.05M | -48.82M | -47.49M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.44 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.29 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.04 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
594.81 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.20 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-07 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-02-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-25 | 개시 | B. Riley Securities | Buy |
| 2020-11-05 | 개시 | Alliance Global Partners | Buy |
| 2017-12-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | 재개 | ROTH Capital | Buy |
| 2017-09-14 | 개시 | Maxim Group | Buy |
| 2016-08-25 | 개시 | ROTH Capital | Buy |
| 2016-02-29 | 개시 | H.C. Wainwright | Buy |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2014-10-01 | 개시 | MLV & Co | Buy |
| 2014-07-22 | 개시 | Canaccord Genuity | Buy |
모두보기
Actinium Pharmaceuticals Inc 주식(ATNM)의 최신 뉴스
Can machine learning forecast Actinium Pharmaceuticals Inc. recoveryMarket Forecast Summary Over Multi-Year Period - Newser
What institutional flow reveals about Actinium Pharmaceuticals Inc.Long Term Stock Growth Plan Suggestions - Newser
How to interpret RSI for Actinium Pharmaceuticals Inc. stockFree Trade Insight With Community Collaboration - Newser
Using Bollinger Bands to evaluate Actinium Pharmaceuticals Inc. Quarterly Investment Outlook and Key Summary - Newser
What are the latest earnings results for Actinium Pharmaceuticals Inc.Tremendous portfolio expansion - jammulinksnews.com
What is the risk reward ratio of investing in Actinium Pharmaceuticals Inc. stockBreakout stock performance - jammulinksnews.com
Is it the right time to buy Actinium Pharmaceuticals Inc. stockUnprecedented profits - jammulinksnews.com
What is Actinium Pharmaceuticals Inc. company’s growth strategyFree Real-Time Stock Data - jammulinksnews.com
When is Actinium Pharmaceuticals Inc. stock expected to show significant growthGrow your wealth with proven stock picks - jammulinksnews.com
Actinium Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveFree Access to Community - Newser
Is Actinium Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Free Stock Market Real-Time Monitoring - Newser
Actinium Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowMassive Gain Ideas - Newser
Actinium Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsStrong Buy Recommendations - Newser
Is Actinium Pharmaceuticals Inc. stock a growth or value playProfessional Stock Screener - Newser
Key External Factors That Drive Actinium Pharmaceuticals Inc. Stock Price MovementsSmart Money Trade Setups - Newser
What institutions are buying Actinium Pharmaceuticals Inc. stock nowSuperior investment outcomes - jammulinksnews.com
What drives Actinium Pharmaceuticals Inc. stock priceAccelerated wealth expansion - PrintWeekIndia
Is Actinium Pharmaceuticals Inc. a good long term investmentRapid growth opportunities - Autocar Professional
What analysts say about Actinium Pharmaceuticals Inc. stockHigh-yield growth strategies - PrintWeekIndia
What analysts say about Actinium Pharmaceuticals Inc. stock outlookUnbelievable profit margins - jammulinksnews.com
Actinium Pharmaceuticals Inc. Stock Analysis and ForecastHigh-performance investment picks - jammulinksnews.com
Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Protected Stock Selections - Newser
Lead Plaintiff Appointed in Actinium Pharmaceuticals Class Action - TradingView
How Actinium Pharmaceuticals Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser
What makes Actinium Pharmaceuticals Inc. stock price move sharplyFree Investment Group - Newser
Actinium Highlights ATNM 400 Progress at SNMMI Conference - Yahoo.co
Actinium Pharmaceuticals Inc (ATNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.73%
0.98%
자본화:
|
볼륨(24시간):